Search Results for PCAC

Showing 1 – 3

FDA Considers Compounding Restrictions on Four Drugs, Including Acetaminophen By Alexander Gaffney, RAC - Published 21 May 2015

The US Food and Drug Administration (FDA) is preparing to ask one of its newest advisory committees to decide if some compounding pharmacies should be allowed to make four drugs, including the widely used painkiller acetaminophen.

Categories: News, US, CDER, Drugs

Tags: PCAC, Pharmacy Compounding Advisory Committee, Pharmaceutical Compounding, Compounding

FDA Committee Prepares to Decide if Six Drugs Can be Made by Compounding Pharmacies By Alexander Gaffney, RAC - Published 23 January 2015

The US Food and Drug Administration (FDA) has announced it will soon hold the first meeting of a new and influential advisory committee that is set to make recommendations about which drugs will not be allowed to be made by compounding pharmacies in the US.

Categories: News, US, CDER, Drugs, Postmarket surveillance

Tags: PCAC, Pharmaceutical Compounding, Advisory Committee, Pharmaceutical Compounding Advisory Committee

FDA Appoints Members to New, Influential Advisory Committee By Alexander Gaffney, RAC - Published 16 December 2014

Almost a year after announcing the re-creation of its Pharmacy Compounding Advisory Committee (PCAC), the US Food and Drug Administration (FDA) has announced that it has selected 12 experts who will serve on the influential committee as it considers how best to regulate the pharmaceutical compounding sector.

Categories: News, US, CDER, Drugs

Tags: PCAC, Pharmacy Compounding Advisory Committee, Difficult-to-Compound List, AdComm, Advisory Committee